moleculon inc said successfully completed initial tests animals its poroplastic transdermal nicotine delivery system help smokers break habit transdermal systems designed deliver drugs through skin constant dosages company said discussing licensing and marketing agreements for product with major international pharmaceutical firm but did not identify firm also said retained allen and company new york its financial advisor reuter 